Prospects and Challenges of Nanotechnology in the Treatment of Pediatric Diseases

As a new approach, nanotechnology has opened up new horizons in disease diagnosis and treatment. Nanotechnology, utilizing nanomaterials and targeted drug delivery systems, has addressed numerous challenges in treating pediatric diseases. Pediatric diseases present unique challenges in treatment management due to the specific physiological characteristics of this age group, including the need for accurate drug dosages, minimizing side effects, and enhancing treatment efficacy. Nanotechnology offers groundbreaking applications in the diagnosis and treatment of childhood diseases, providing targeted therapies with enhanced efficacy and reduced side effects. Key applications include nano-drug delivery systems for the precise treatment of pediatric cancers (e.g., leukemia and brain tumors), nanosensors for the early detection of metabolic and infectious diseases, and nanoparticle-based inhalable therapies for respiratory conditions such as asthma. Additionally, nanotechnology enables improved bioavailability and reduced drug dosages, critical for pediatric patients. However, challenges such as long-term safety, biocompatibility, and regulatory hurdles remain. Future directions include the development of multifunctional nanoplatforms for combination therapy and personalized medicine, alongside advances in scalable and cost-effective manufacturing. Addressing these challenges will be essential for translating nanomedicine into mainstream pediatric healthcare.

کلیدواژه ها:

cancer ، Drug Delivery ، Genetic Diseases ، Nanocapsules ، Nanoparticles